Onconetix, Inc. Notes Issued
Onconetix, Inc. (ONCO) reported Notes Issued of $5.13 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-06-02.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:NotesIssued1 · last filed 2025-11-13
- Onconetix, Inc. notes issued for the quarter ending 2024-12-31 was $0.00.
- Onconetix, Inc. notes issued for fiscal 2024 was $5.13M.
| Period end | Notes Issued 3 month | Notes Issued 9 month | Notes Issued 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-02 | $5.13M 10-K · filed 2025-06-02 | |
| 2024-09-30 | $5.13M 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |